| Company Name: |
Shanghai YuanQi Biotechnology Co., Ltd.
|
| Tel: |
+86-2332782371 +86-18120098618 |
| Email: |
sales@adobechem.com |
| Products Intro: |
Product Name:4-(6-chloro-2-methoxyacridin-9-ylamino)-2-((4-methylpiperazin-1-yl)methyl)phenol
CAS:1082532-95-3
Purity:>95% HPLC Package:1g,5g,10g
|
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Products Intro: |
Product Name:NSC130813
CAS:1082532-95-3
Purity:>=98% (HPLC) Package:5MG Remarks:SML0922-5MG
|
|
| Product Name: | NERI02 | | Synonyms: | 4-[(6-Chloro-2-methoxy-9-acridinyl)amino]-2-[(4-methyl-1-piperazinyl)methyl]-phenol trihydrochloride;F06;NERI02;NSC130813;HM03 trihydrochloride;NSC130813 >=98% (HPLC) | | CAS: | 1082532-95-3 | | MF: | C26H28Cl2N4O2 | | MW: | 499.44 | | EINECS: | | | Product Categories: | | | Mol File: | 1082532-95-3.mol |  |
| | NERI02 Chemical Properties |
| storage temp. | -20°C | | solubility | H2O: soluble10mg/mL, clear | | form | powder | | color | yellow to orange |
| | NERI02 Usage And Synthesis |
| Biochem/physiol Actions | NSC130813 blocks protein-protein interactions between XPF and ERCC1, two proteins involved in nucleotide excision repair (NER). The compound, NSC130813, blocks repair of DNA damage induced by platinum-based ctyotoxic drugs and DNA alkylating agents. NSC130813 synergistically potentiates cell death in cancer cell lines treated with cisplatin or mitomycin C. |
| | NERI02 Preparation Products And Raw materials |
|